Literature DB >> 27095559

Neighborhood Socioeconomic Characteristics and Utilization of ADHD Medication in Schoolchildren: A Population Multilevel Study in Stockholm County.

Beata Jablonska1,2, Kyriaki Kosidou1,2, Antonio Ponce de Leon1,2, Björn Wettermark2, Cecilia Magnusson1,2, Henrik Dal1,2, Christina Dalman1,2.   

Abstract

Objective: To examine the effects of neighborhood socioeconomic disadvantage and ethnic composition on the utilization of ADHD medication in schoolchildren after accounting for individual- and family-level characteristics. Method: A cohort of all schoolchildren living in Stockholm County was prospectively followed for new prescriptions of ADHD medication (N = 276,955). Three-level logistic regression models were used with individual/family characteristics (e.g., immigrant background) at the first level and small area market statistics (SAMS) and municipality characteristics (i.e., socioeconomic disadvantage and ethnic composition) at the second and third level.
Results: SAMS socioeconomic disadvantage was associated with increased utilization of ADHD medication. The utilization of ADHD medication was lower among immigrant children as compared with natives, and their odds of not utilizing medication increased as the degree of concentration of foreign-born increased.
Conclusion: These results suggest that interventions at the neighborhood level may offer an additional route for the prevention of the disorder and/or alleviation of its consequences.

Entities:  

Keywords:  ADHD; SES; epidemiology; ethnic minorities; school-age children

Year:  2016        PMID: 27095559     DOI: 10.1177/1087054716643257

Source DB:  PubMed          Journal:  J Atten Disord        ISSN: 1087-0547            Impact factor:   3.256


  8 in total

1.  Risk of Psychiatric Disorders Among Refugee Children and Adolescents Living in Disadvantaged Neighborhoods.

Authors:  Else Foverskov; Justin S White; Trine Frøslev; Henrik T Sørensen; Rita Hamad
Journal:  JAMA Pediatr       Date:  2022-09-12       Impact factor: 26.796

2.  Perceived barriers to care for migrant children and young people with mental health problems and/or neurodevelopmental differences in high-income countries: a meta-ethnography.

Authors:  Vanessa Place; Benjamin Nabb; Ester Gubi; Karima Assel; Johan Åhlén; Ana Hagström; Sofie Bäärnhielm; Christina Dalman; Anna-Clara Hollander
Journal:  BMJ Open       Date:  2021-09-16       Impact factor: 3.006

3.  ADHD medication in offspring of immigrants - does the income level of the country of parental origin matter?

Authors:  Arzu Arat; Viveca Östberg; Bo Burström; Anders Hjern
Journal:  BMC Psychiatry       Date:  2018-01-08       Impact factor: 3.630

4.  Overuse of methylphenidate: an analysis of Swedish pharmacy dispensing data.

Authors:  Pernilla J Bjerkeli; Raquel Perez Vicente; Shai Mulinari; Kristina Johnell; Juan Merlo
Journal:  Clin Epidemiol       Date:  2018-11-09       Impact factor: 4.790

5.  Differences in psychiatric care utilisation among unaccompanied refugee minors, accompanied migrant minors, and Swedish-born minors.

Authors:  Lovisa Axelsson; Sofie Bäärnhielm; Christina Dalman; Anna-Clara Hollander
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2020-05-13       Impact factor: 4.328

6.  Maternal Sociodemographic Factors Are Associated with Methylphenidate Initiation in Children in the Netherlands: A Population-Based Study.

Authors:  K Cheung; H El Marroun; B Dierckx; L E Visser; B H Stricker
Journal:  Child Psychiatry Hum Dev       Date:  2021-04

7.  Family Income Mediates the Effect of Parental Education on Adolescents' Hippocampus Activation During an N-Back Memory Task.

Authors:  Shervin Assari; Shanika Boyce; Mohsen Bazargan; Cleopatra H Caldwell
Journal:  Brain Sci       Date:  2020-08-05

8.  Mental health service use among migrant and Swedish-born children and youth: a register-based cohort study of 472,129 individuals in Stockholm.

Authors:  Ester Gubi; Hugo Sjöqvist; Karima Viksten-Assel; Sofie Bäärnhielm; Christina Dalman; Anna-Clara Hollander
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2021-07-28       Impact factor: 4.328

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.